Patents by Inventor Roberto Tonani

Roberto Tonani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Condensed heterocyclic pyrazole derivatives as kinase inhibitors
    Patent number: 8017643
    Abstract: Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.
    Type: Grant
    Filed: July 21, 2010
    Date of Patent: September 13, 2011
    Assignee: Nerviano Medical Sciences S.R.L.
    Inventors: Roberto Tonani, Simona Bindi, Daniele Fancelli, Valeria Pittala′, Mario Varasi
  • Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
    Publication number: 20100286223
    Abstract: Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.
    Type: Application
    Filed: July 21, 2010
    Publication date: November 11, 2010
    Applicant: PFIZER ITALIA S.R.L.
    Inventors: Roberto Tonani, Simona Bindi, Daniele Fancelli, Valeria Pittala', Mario Varasi
  • Condensed heterocyclic pyrazole derivatives as kinase inhibitors
    Patent number: 7786048
    Abstract: Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: August 31, 2010
    Assignee: Pfizer Italia S.r.l.
    Inventors: Roberto Tonani, Simona Bindi, Daniele Fancelli, Valeria Pittala′, Mario Varasi
  • Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors
    Publication number: 20090233813
    Abstract: Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.
    Type: Application
    Filed: May 27, 2009
    Publication date: September 17, 2009
    Applicant: PFIZER ITALIA S.R.L.
    Inventors: Roberto Tonani, Simona Bindi, Daniele Fancelli, Valeria Pittala', Mario Varasi
  • Condensed heterocyclic pyrazole derivatives as kinase inhibitors
    Patent number: 7541378
    Abstract: Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: June 2, 2009
    Assignee: Pfizer Italia S.r.l.
    Inventors: Roberto Tonani, Simona Bindi, Daniele Fancelli, Valeria Pittala′, Mario Varasi
  • Heterobicyclic pyrazole derivatives as kinase inhibitors
    Patent number: 7485661
    Abstract: Bicyclo-pyrazoles of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: February 3, 2009
    Assignee: Pfizer Italia S.r.l.
    Inventors: Roberto Tonani, Simona Bindi, Daniele Fancelli, Valeria Pittala′, Matteo D'Anello
  • Heterobicyclic pyrazole derivatives as kinase inhibitors
    Publication number: 20060160874
    Abstract: Bicyclo-pyrazoles of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
    Type: Application
    Filed: January 18, 2005
    Publication date: July 20, 2006
    Applicant: Pharmacia Italia S.p.A.
    Inventors: Roberto Tonani, Simona Bindi, Daniele Fancelli, Valeria Pittala', Matteo D' Anello
  • Condensed heterocyclic pyrazole derivatives as kinase inhibitors
    Publication number: 20060122249
    Abstract: Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.
    Type: Application
    Filed: July 11, 2003
    Publication date: June 8, 2006
    Inventors: Roberto Tonani, Simon Bindi, Daniele Fancelli, Valeria Pittala', Mario Varasi